Allison Buczynski
Family · Weirton, WVNPI 1407498850
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 197 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 16.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,187 and has fallen 96.6% since, to $40 in 2025.
Across 197 payments — averaging $16.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$515
- Novartis$378
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$320
- Boehringer Ingelheim$275
- Amgen$249
- Bayer$203
- plus $1K from 19 others
What the payments were for
- Food & beverage$3,196100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 32 | $515 |
| Novartis | 25 | $378 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 20 | $320 |
| Boehringer Ingelheim | 18 | $275 |
| Amgen | 17 | $249 |
| Bayer | 11 | $203 |
| Johnson & Johnson | 13 | $191 |
| Amarin Pharma, Inc. | 9 | $153 |
| Merck | 8 | $128 |
| Lilly USA, LLC | 7 | $112 |
| Mylan Specialty L.p. | 6 | $108 |
| Sanofi-aventis U.S. LLC | 5 | $85 |
| Lexicon Pharmaceuticals, Inc. | 3 | $83 |
| AbbVie | 4 | $77 |
| Daiichi Sankyo Inc. | 4 | $63 |
| E.r. Squibb & Sons, L.L.C. | 3 | $47 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $43 |
| Novo Nordisk | 3 | $43 |
| Phathom Pharmaceuticals, Inc. | 1 | $24 |
| Actelion Pharmaceuticals US, Inc. | 1 | $23 |
| GSK | 1 | $20 |
| Shield Therapeutics Inc | 1 | $19 |
| Pfizer | 1 | $15 |
| Medicomp Inc | 1 | $13 |
| Esperion Therapeutics, Inc. | 1 | $11 |
How this compares
$3,196 in reported general payments places this provider in the 85th percentile of 1,507 family providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 11 | $24 |
Paid to pharmacies, not to this prescriber.
Other family in Weirton
- Anthony ReesWeirton$7K
- Ashley ComerCharleston$213K
- Dana CruseParkersburg$109K
- Sarah KnightCharleston$99K
- Star RoeBarboursville$55K
- Angela SettleCharleston$51K
- Amber DuncanCross Lanes$44K
- Jennifer FieldsHuntington$32K
- Gina LatheyScott Depot$31K
- Jodi BillerScott Depot$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.